Read more at:https://health.economictimes.indiatimes.com/news/industry/avesthagen-wipro-launch-genetic-test-for-cancers-neurological-rare-diseases/92360164

Avesthagen Limited on Monday announced that it has entered into a four-year strategic alliance with Wipro Limited for making its genetic testing portfolio commercial. According…

NEW YORK – Indian biotechnology company Avesthagen said on Monday that it has entered into a four-year strategic alliance with Wipro, an Indian information technology…

Reversible epigenetic changes within the loci of genes that regulate critical cell processes have recently emerged as important biomarkers of disease pathology. It is then…

The present-day Zoroastrian-Parsis have roots in ancient pastoralist migrations from circumpolar regions leading to their settlement on the Eurasian Steppes and later, as Indo-Iranians in…

With the advent of Next Generation Sequencing, many population specific whole genome sequences published thus far, predominantly represent individuals of European ancestry. While sequencing efforts…

Since 2008, the Avestagenome Project® has been collecting a biobank of Parsi blood samples and extensive patient data from over 4,500 members of this community…

BANGALORE, India, Dec. 12, 2019 /PRNewswire/ -- Avesthagen Limited, a leading systems biology life sciences company, announces the acceleration of its Avestagenome Project®. This research study focuses on the…

The A V E S T A G E N O M E Project™ is a systems-biology-based study of the Parsis, a genetically homogeneous community,…